Method of Cardiac Imaging

Mathilde Hauge Lerche; Rene Zandt; Klaes Golman; Mikkel Thanning; Jan Henrik Ardenkjær-Larsen; Stefan Petersson

Method of Cardiac Imaging

Mathilde Hauge Lerche (Inventor)
, Rene Zandt (Inventor)
, Klaes Golman (Inventor)
, Mikkel Thanning (Inventor)
, Jan Henrik Ardenkjær-Larsen (Inventor)
, Stefan Petersson (Inventor)

GE Healthcare

Research output: Patent

95 Downloads (Orbit)

Abstract

The invention relates to a method of cardiac imaging using hyperpolarised 13C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.

Original language	English
IPC	A61B 5/ 055 A I
Patent number	US2009162287
Filing date	25/06/2009
Country/Territory	United States
Priority date	18/11/2005
Priority number	WO2005NO00434
Publication status	Published - 25 Jun 2009
Externally published	Yes

Bibliographical note

Also published as: US8980224 (B2) WO2006054903 (A2) WO2006054903 (A3) RU2007118383 (A) RU2391047 (C2) MX2007006048 (A) KR20070089171 (A) KR101249634 (B1) JP2008520335 (A) JP5456256 (B2) ES2422558 (T3) EP1824523 (A2) EP1824523 (B1) CN101102799 (A) CN101102799 (B) CA2587795 (A1) CA2587795 (C) BRPI0518302 (A2) AU2005307194 (A1) AU2005307194 (B2)

Access to Document

US2009162287A1 cardiacFinal published version, 1.07 MB

OpenUrl availability

Check availability in DTU Findit

Cite this

@misc{7225e62015a84530bc92d7f02758fa67,

title = "Method of Cardiac Imaging",

abstract = "The invention relates to a method of cardiac imaging using hyperpolarised 13C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.",

author = "Lerche, \{Mathilde Hauge\} and Rene Zandt and Klaes Golman and Mikkel Thanning and Ardenkj{\ae}r-Larsen, \{Jan Henrik\} and Stefan Petersson",

note = "Also published as: US8980224 (B2) WO2006054903 (A2) WO2006054903 (A3) RU2007118383 (A) RU2391047 (C2) MX2007006048 (A) KR20070089171 (A) KR101249634 (B1) JP2008520335 (A) JP5456256 (B2) ES2422558 (T3) EP1824523 (A2) EP1824523 (B1) CN101102799 (A) CN101102799 (B) CA2587795 (A1) CA2587795 (C) BRPI0518302 (A2) AU2005307194 (A1) AU2005307194 (B2) ; US2009162287; A61B 5/ 055 A I",

year = "2009",

month = jun,

day = "25",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Method of Cardiac Imaging

AU - Lerche, Mathilde Hauge

AU - Zandt, Rene

AU - Golman, Klaes

AU - Thanning, Mikkel

AU - Ardenkjær-Larsen, Jan Henrik

AU - Petersson, Stefan

N1 - Also published as: US8980224 (B2) WO2006054903 (A2) WO2006054903 (A3) RU2007118383 (A) RU2391047 (C2) MX2007006048 (A) KR20070089171 (A) KR101249634 (B1) JP2008520335 (A) JP5456256 (B2) ES2422558 (T3) EP1824523 (A2) EP1824523 (B1) CN101102799 (A) CN101102799 (B) CA2587795 (A1) CA2587795 (C) BRPI0518302 (A2) AU2005307194 (A1) AU2005307194 (B2)

PY - 2009/6/25

Y1 - 2009/6/25

N2 - The invention relates to a method of cardiac imaging using hyperpolarised 13C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.

AB - The invention relates to a method of cardiac imaging using hyperpolarised 13C-pyruvate as MR imaging agent, which allows determination of the viability of cells in the myocardium.

M3 - Patent

M1 - US2009162287

Y2 - 2009/06/25

ER -

Method of Cardiac Imaging

Abstract

Bibliographical note

Access to Document

OpenUrl availability

Fingerprint

Cite this